Thymopoietin (TMPO) (N-Term) Peptid
-
- Target Alle Thymopoietin (TMPO) Produkte
- Thymopoietin (TMPO)
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-TMPO antibody (Catalog #: ARP44798_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Thymopoietin (TMPO)
- Hintergrund
-
TMPO may be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. It plays an important role, together with LMNA, in the nuclear anchorage of RB1.
Alias Symbols: CMD1T, LAP2, MGC61508, PRO0868, TP, LEMD4
Protein Interaction Partner: RB1,AKAP8L,BANF1,GMCL1,LMNA,LMNB1,RB1,SGTA,SGTB,USP7,AKAP8L,BANF1,Gmcl1,LMNA,LMNB1,LMNB2,RB1
Protein Size: 345 - Molekulargewicht
- 39 kDa
- Gen-ID
- 7112
- NCBI Accession
- NM_001032284, NP_001027455
-